Prosecution Insights
Last updated: April 19, 2026

Fortvita Biologics (Singapore) Pte. Ltd.

3 pending office actions

Portfolio Summary

3
Total Pending OAs
0
Final Rejections
3
Non-Final OAs

Pending Office Actions

App #TitleExaminerArt UnitStatusFiled
18246939 ANTI-CLAUDIN18.2 AND CD3 BISPECIFIC ANTIBODY AND USE THEREOF KAUFMAN, CLAIRE M 1674 Non-Final OA Mar 28, 2023
18010944 ANTI-CLAUDIN18.2 ANTIBODY AND USE THEREOF KAUFMAN, CLAIRE M 1674 Non-Final OA Dec 16, 2022
17911922 INTERLEUKIN-2 MUTANT AND USE THEREOF PATTERSON, SARAH COOPER 1675 Non-Final OA Sep 15, 2022

Managing Fortvita Biologics (Singapore) Pte. Ltd.'s Patent Portfolio?

IP Author helps IP teams respond to office actions faster with AI-generated responses, examiner analytics, and prosecution intelligence.

Start Free Trial

Sign in with your work email

Enter your email to receive a magic link. No password needed.

Personal email addresses (Gmail, Yahoo, etc.) are not accepted.

Free tier: 3 strategy analyses per month